Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Schotten

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Liver Cancer|July 11, 2020
Reply to the Letter to the Editor: "Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma"Clemens Schotten, Heiner Wedemeyer, Jan Best
Expert Opinion on Pharmacotherapy|April 18, 2017
Tivantinib for the treatment of hepatocellular carcinomaJan Best, Clemens Schotten, Gregor Lohmann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 10, 2017
Jens Theysohn, Clemens Schotten, Maren Schulze, et al.
European Journal of Medical Research|May 26, 2022
Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?Tamás Benkö, Julia König, Jens M Theysohn, et al.
Annals of Gastroenterology|January 3, 2017
Novel implications in the treatment of hepatocellular carcinomaJan Best, Clemens Schotten, Jens M Theysohn, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 5, 2020
DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional TherapiesJohannes Haubold, Markus P Reinboldt, Axel Wetter, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C PatientsClemens Schotten, Bastian Ostertag, Jan-Peter Sowa, et al.
Liver Cancer|December 5, 2019
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationClemens Schotten, Lars P Bechmann, Paul Manka, et al.
Cancers|October 14, 2022
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisCatherine Leyh, Niklas Heucke, Clemens Schotten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Liver Cancer|July 11, 2020
Reply to the Letter to the Editor: "Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma"Clemens Schotten, Heiner Wedemeyer, Jan Best
Expert Opinion on Pharmacotherapy|April 18, 2017
Tivantinib for the treatment of hepatocellular carcinomaJan Best, Clemens Schotten, Gregor Lohmann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 10, 2017
Jens Theysohn, Clemens Schotten, Maren Schulze, et al.
European Journal of Medical Research|May 26, 2022
Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?Tamás Benkö, Julia König, Jens M Theysohn, et al.
Annals of Gastroenterology|January 3, 2017
Novel implications in the treatment of hepatocellular carcinomaJan Best, Clemens Schotten, Jens M Theysohn, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 5, 2020
DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional TherapiesJohannes Haubold, Markus P Reinboldt, Axel Wetter, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C PatientsClemens Schotten, Bastian Ostertag, Jan-Peter Sowa, et al.
Liver Cancer|December 5, 2019
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationClemens Schotten, Lars P Bechmann, Paul Manka, et al.
Cancers|October 14, 2022
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisCatherine Leyh, Niklas Heucke, Clemens Schotten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Pageof 1